Immunotherapy News and Research

Latest Immunotherapy News and Research

Compound could play a novel role in halting spread of pancreatic cancer

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

18 Sep 2019

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

18 Sep 2019

Attana invited to showcase latest applications at National University of Singapore's Life Sciences day

Attana is invited to present at the National University of Singapore's Life Sciences Institute Core Facilities Day - NUS Medical Sciences Cluster on Thursday September 20th. In particular, Attana is invited to show Attana's leading applications for interaction characterization of CAR-T cells and tumor tissues.

17 Sep 2019

Research may provide better tools for designing personalized protocols for cancer patients

Diversity – at least among cancer cells – is not a good thing. Now, research from the Weizmann Institute of Science shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective.

17 Sep 2019

B-cell subtypes play essential role in immune response to melanoma

When it comes to further developing modern immunotherapies, cancer research has so far concentrated on T-lymphocytes.

13 Sep 2019

Editing away cancer and HIV in China: win or lose?

Scientists in China recently edited out the CCR5 gene from a patient with HIV's stem cells, but the research has sparked ethical debate.

13 Sep 2019

B cells may play an important role in immunotherapy for melanoma

Researchers at EMBL's European Bioinformatics Institute and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma.

13 Sep 2019

Mount Sinai awarded $1.7 million to study how bladder cancer affects 'natural killer' cells

The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called "natural killer" cells, or NK cells, which control and limit tumor growth.

12 Sep 2019

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.

12 Sep 2019

New liquid biopsy test may be more predictive of patient's immunotherapy response

A new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it could help determine which patients are likely to respond to immune checkpoint inhibitors.

11 Sep 2019

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Tel Aviv University and Sheba Medical Center researchers say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments.

10 Sep 2019

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.

10 Sep 2019

Lilly launches new report highlighting challenges and opportunities of health care revolution

Eli Lilly and Company today calls on industry, academia and the NHS to do more to foster collaboration to ensure the UK maintains its global leadership position at the forefront of medicines research and discovery.

9 Sep 2019

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.

8 Sep 2019

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

People living with inflammatory autoimmune disease could benefit from an 'immune system reboot', and researchers have isolated specific cells to target.

7 Sep 2019

Cancer patients with low income and no insurance see fewer trial benefits

When it comes to benefiting from experimental treatments offered in cancer clinical trials, your health insurance status and where you live matters, according to results of two new research studies to be presented at the 2019 ASCO Quality Care Symposium, held September 6 and 7 in San Diego.

5 Sep 2019

A factor that predicts prolonged survival in brain tumor uncovered

The discoveries in the cellular and molecular biology of cancer, the development of drugs against specific genetic mutations, and the emergence of immunotherapy are allowing the cure or improvement of the quality of life and life expectancy of patients with tumors.

3 Sep 2019

Study gives insight into how immunotherapies may be delivered directly to brain tumors

A new study gives insight into how immunotherapies, treatments that help the body's immune system fight cancer, might one day be delivered directly to the brain in order to treat brain tumors.

29 Aug 2019

Researchers find a weak spot in cancer cells

Cancer cells form tumors. This statement, simple as it seems, hides a complex failure of normal immune responses that should eliminate tumor cells from the body before they ever form viable cancer masses.

28 Aug 2019

Novel immunotherapy method could overcome tumor immunity

Cancer immunotherapy is a form of treatment in which the body’s own immune cells are recruited to overcome the tumor. However, it is only useful in a few tumors, because of tumor immunity where tumor-associated immune cells work to protect the tumor against attack.

28 Aug 2019

Immunotherapy News and Research

Latest Immunotherapy News and Research

Compound could play a novel role in halting spread of pancreatic cancer

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

Attana invited to showcase latest applications at National University of Singapore's Life Sciences day

Research may provide better tools for designing personalized protocols for cancer patients

B-cell subtypes play essential role in immune response to melanoma

Editing away cancer and HIV in China: win or lose?

B cells may play an important role in immunotherapy for melanoma

Mount Sinai awarded $1.7 million to study how bladder cancer affects 'natural killer' cells

CAR T-cell therapy may be viable treatment option for heart disease

New liquid biopsy test may be more predictive of patient's immunotherapy response

'Protein mapping' approach reveals why metastatic melanoma patients do not respond to immunotherapy

Mutations linked with sensitivity or resistance to immunotherapy in mNSCLC

Lilly launches new report highlighting challenges and opportunities of health care revolution

Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study reveals

Tiny fat bubbles hold key to rebooting the immune system and calming disease process

Cancer patients with low income and no insurance see fewer trial benefits

A factor that predicts prolonged survival in brain tumor uncovered

Study gives insight into how immunotherapies may be delivered directly to brain tumors

Researchers find a weak spot in cancer cells

Novel immunotherapy method could overcome tumor immunity

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in